Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-18
2007-09-18
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S368000
Reexamination Certificate
active
11222452
ABSTRACT:
Disclosed are novel heterocyclic compounds having the structurewhich are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
REFERENCES:
patent: 4558129 (1985-12-01), Kluge et al.
patent: 4567264 (1986-01-01), Kluge et al.
patent: 4766125 (1988-08-01), Van Daele
patent: 5472707 (1995-12-01), Samuels et al.
patent: 5506229 (1996-04-01), Dow et al.
patent: 5906988 (1999-05-01), Dow
patent: 6451798 (2002-09-01), Varkhedkar et al.
patent: 6552023 (2003-04-01), Zablocki et al.
patent: 6573264 (2003-06-01), Zablocki et al.
patent: 6638970 (2003-10-01), Elzein et al.
patent: 6677336 (2004-01-01), Zablocki et al.
patent: 6677343 (2004-01-01), Blackburn et al.
patent: 2003/0181352 (2003-09-01), Ibrahim et al.
patent: 2005/0153981 (2005-07-01), Li et al.
Tang-Wai et al. Biochemistry,vol. 34, p. 32-39 (1995).
U.S. Appl. No. 10/729,499, filed Dec. 5, 2003, Elzein et al.
Koltun Dmitry
Zablocki Jeff
Bernhardt Emily
CV Therapeutics Inc.
Hartrum J. Elin
LandOfFree
Substituted heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3802357